Spanish fund manager Portobello Capital has attracted commitments totalling €570m for its fourth buyout fund, Portobello Capital Fondo IV, and is nearing a final close before year-end.
Buyout and exit volume dropped dramatically in the first half of 2020, while GPs are doubling down on technology-driven strategies
Also backing the biotech startup were the Zürcher Kantonalbank and Greencross Medical Science Corp
Company plans to use the fresh capital to further expand, develop new features and scale up its team
EVentures, 468 Capital and HV Holtzbrinck back the round for the climate change mitigation app